Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease
Commentary on Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease
Top Things to Know: Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease
Slide Set - Given the rapid evolution of data in the cardiorenal-metabolic space, a brief update is also provided highlighting the major new trials in this topic that reported data after the timeline of this scientific statement ( March 31, 2020) (PDF)
News Release: Newer Type 2 diabetes medications have heart and kidney disease benefits, too
2017 Focused Update of the 2013 Guideline for the Management of Heart Failure
2016 Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 Guideline for the Management of Heart Failure
2013 Guideline for the Management of Heart Failure
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure
Update on Prevention of Cardiovascular Disease in Adults with Type 2 Diabetes Mellitus in Light of Recent Evidence
